NASDAQ$BTTC

Black Titan Corp · Q2 2016 earnings

Q2 2016 earnings · · Investor relations

Headline financials

Total Revenue

$15M

Previous: $760K+1874.2%
Capital Expenditures

-$9K

Previous: $2K-550.0%
Net Income

$11.9M

Previous: -$2.28M+622.9%
Operating Income

$12M

Previous: -$1.09M+1202.9%
Gross Profit

$13.3M

Previous: -$339K+4010.9%
Cash & Equivalents

$19.3M

Previous: $11.5M+67.9%
Total Assets

$25.3M

Previous: $17.3M+46.1%
Stock-Based Comp

$249K

Previous: $76K+227.6%

Revenue & EPS history

Titan Pharmaceuticals · Revenue · Quarterly

$15M

Q2 2016+1,874.2%vs Q2 2015
Beat estimate in 6 of 9 quarters(67%)
ActualEstimate

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro